2015
DOI: 10.1155/2015/729679
|View full text |Cite
|
Sign up to set email alerts
|

Herb-Drug Pharmacokinetic Interaction of a Traditional Chinese Medicine Jia-Wei-Xiao-Yao-San with 5-Fluorouracil in the Blood and Brain of Rat Using Microdialysis

Abstract: According to a survey from the National Health Insurance Research Database (NHIRD), Jia-Wei-Xiao-Yao-San (JWXYS) is the most popular Chinese medicine for cancer patients in Taiwan. 5-Fluorouracil (5-FU) is a general anticancer drug for the chemotherapy. To investigate the herb-drug interaction of JWXYS on pharmacokinetics of 5-FU, a microdialysis technique coupled with a high-performance liquid chromatography system was used to monitor 5-FU in rat blood and brain. Rats were divided into four parallel groups, o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 37 publications
(41 reference statements)
2
12
0
Order By: Relevance
“…Heggie’s study describing the characteristics of 5-FU in intravenously treated patients reported that the half-life and residence time of 5-FU are much shorter than that of its metabolite, 5-FDHU [ 38 ]. No significant correlations in 5-FDHU pharmacokinetic parameters were found between the three dosages levels of XSLJZT used in this study, in agreement with Chiang’s studies [ 10 ]. In conclusion, the present study provides not only a detailed comparison of the herbal–drug pharmacokinetic interaction of 5-FU and its main metabolite 5-FDHU with XSLJZT in rat blood, but warns that 5-FU-associated toxicity must be considered when coupled with high doses of XSLJZT.…”
Section: Resultssupporting
confidence: 92%
See 3 more Smart Citations
“…Heggie’s study describing the characteristics of 5-FU in intravenously treated patients reported that the half-life and residence time of 5-FU are much shorter than that of its metabolite, 5-FDHU [ 38 ]. No significant correlations in 5-FDHU pharmacokinetic parameters were found between the three dosages levels of XSLJZT used in this study, in agreement with Chiang’s studies [ 10 ]. In conclusion, the present study provides not only a detailed comparison of the herbal–drug pharmacokinetic interaction of 5-FU and its main metabolite 5-FDHU with XSLJZT in rat blood, but warns that 5-FU-associated toxicity must be considered when coupled with high doses of XSLJZT.…”
Section: Resultssupporting
confidence: 92%
“…Our findings are supported by our previous study of 5-FU, in which we found no significant differences resulting from concurrent use with the traditional medicines XSLJZT and JWXYS [ 10 ]. Although the results for 5-FU and 5-FDHU did not significantly differ between the 5-FU alone cohort and the group pretreated with a daily dose of XSLJZT (600 mg/kg/day) for five consecutive days, the time-concentration profile indicates that pretreatment with a high-dose of XSLJZT (2400 mg/kg/day) can extend the residence time of 5-FU in blood (that of 5-FDHU is rarely prolonged).…”
Section: Resultssupporting
confidence: 90%
See 2 more Smart Citations
“…e therapeutic effect of this herb could be through the alleviation of psychosomatic stress as a result of colon cancer treatment [20]. With reasonable doses, Jia Wei Xiao Yao San is safe and does not interact with 5-FU in conventional treatment [21].…”
Section: Discussionmentioning
confidence: 99%